AbbVie (ABBV) Earnings Date, Estimates & Call Transcripts $289.85 +3.86 (+1.35%) Closing price 03:59 PM EasternExtended Trading$293.99 +4.14 (+1.43%) As of 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest AbbVie Earnings Summary AbbVie announced Q2 2026 earnings on July 31, 2026, reporting an EPS of $3.65, which beat the consensus estimate of $3.61 by $0.04. Quarterly revenue rose 10.2% year-over-year to $16.99 billion, above the consensus estimate of $16.80 billion. With a trailing EPS of $3.54 and a P/E Ratio of 81.88, AbbVie's earnings are expected to grow 15.30% next year, from $13.92 to $16.05 per share. Upcoming Q3 Earnings DateOct. 30Before Market OpensEstimatedConsensus EPS (Jul. 31) $3.61 Actual EPS (Jul. 31) $3.65 Beat By $0.04 Actual Revenue (Jul. 31) $16.99BQ2 2026 Earnings ResourcesQ2 2026 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingABBV Upcoming EarningsAbbVie's Q3 2026 earnings is estimated for Friday, October 30, 2026, based on past reporting schedules, with a conference call scheduled at 9:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2026 Earnings ReportPowered by Get AbbVie Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AbbVie and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataABBV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABBV Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AbbVie Upcoming Earnings ConsensusReport DateOctober 30, 2026Consensus EPS Estimate$3.73Consensus Revenue Estimate$17.32BAbbVie Analyst EPS Estimates & Company GuidanceLow, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS GuidanceCompany Revenue GuidanceRevenue Estimate at GuidanceQ1 20262$3.01$3.06$3.042.560 - 2.600 - Q2 20262$3.71$3.90$3.813.570 - 3.610 - Q3 20262$3.72$3.76$3.743.730 - 3.770 - Q4 20262$3.69$3.74$3.72FY 20268$14.13$14.46$14.30Q1 20271$3.27$3.27$3.27Q2 20271$4.03$4.03$4.03Q3 20271$4.30$4.30$4.30Q4 20271$4.15$4.15$4.15FY 20274$15.75$15.75$15.75 AbbVie Earnings History by Quarter 10/29/2024 - 10/29/2026 Report Date Report Date From Report Date To 3M6MYTD1Y2Y3Y5Y10Y More filters Fewer filters Done 0 Results Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/30/2026(Estimated)-$3.73---$17.32B-7/31/2026Q2 2026$3.61$3.65+$0.04$2.03$16.80B$16.99B4/29/2026Q1 2026$2.59$2.65+$0.06$0.39$14.72B$15.00B2/4/2026Q4 2025$2.65$2.71+$0.06$1.02$16.39B$16.62B10/31/2025Q3 2025$1.77$1.86+$0.09$0.10$15.58B$15.78B7/31/2025Q2 2025$3.24$2.97 -$0.27$0.52$14.93B$15.42B4/25/2025Q1 2025$2.40$2.46+$0.06$0.72$12.91B$13.34B1/31/2025Q4 2024$2.98$2.16 -$0.82-$0.02$14.81B$15.10B10/30/2024Q3 2024$2.92$3.00+$0.08$5.12$14.28B$14.46B AbbVie Earnings - Frequently Asked Questions When is AbbVie's earnings date? AbbVie has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 30th, 2026 based off last year's report dates. Learn more on ABBV's earnings history. What guidance has AbbVie issued on next quarter's earnings? AbbVie updated its third quarter 2026 earnings guidance on Tuesday, October, 6th. The company provided EPS guidance of 3.730-3.770 for the period, compared to the consensus earnings per share estimate of 3.850. The company issued revenue guidance of -. Did AbbVie beat their earnings estimates last quarter? In the previous quarter, AbbVie (NYSE:ABBV) reported $3.65 earnings per share (EPS) to beat the analysts' consensus estimate of $3.61 by $0.04. Learn more on analysts' earnings estimate vs. ABBV's actual earnings. How can I listen to AbbVie's earnings conference call? The conference call for AbbVie's latest earnings report can be listened to online. Listen to Conference Call How can I read AbbVie's conference call transcript? The conference call transcript for AbbVie's latest earnings report can be read online. Read Transcript How can I view AbbVie's earnings report? AbbVie's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded annual revenue of $61.16 billion. How much profit does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded net income of $4.23 billion. ABBV has generated $3.54 earnings per share over the last four quarters. What is AbbVie's price-to-earnings ratio? AbbVie (NYSE:ABBV) has a trailing price-to-earnings ratio of 81.91 and a forward price-to-earnings ratio of 20.82. The price/earnings-to-growth ratio is 1.3. What is AbbVie's EPS forecast for next year? AbbVie's earnings are expected to grow from $13.92 per share to $16.05 per share in the next year, which is a 15.30% increase. More Earnings Resources from MarketBeat Related Companies Amgen Earnings Results Gilead Sciences Earnings Results Moderna Earnings Results Abbott Laboratories Earnings Results Astrazeneca Earnings Results Bristol Myers Squibb Earnings Results Johnson & Johnson Earnings Results Eli Lilly and Company Earnings Results Merck & Co., Inc. Earnings Results Pfizer Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Where's the Beef? Trian-Led Buyout Proposal Values Wendy's at $1.4B, But Is It Enough?Alphabet’s Cloud Is Paying Off—But the Bill for Building It Keeps GrowingPlugging In: Vertiv Cashes In On AI DemandGE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.Phillips 66 Posts Strong Earnings But the Stock Doesn't CareConstellation Energy's Nuclear Expansion Gets a $5 Billion Opening, Not a GuaranteeVisa's Toll Booth Keeps Collecting, But the Price Is Rising Earnings data for NYSE:ABBV is sourced from Fiscal.ai, with the most recent quarter reported on 7/31/2026. New results are added as companies report their earnings. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe "velvet rope" stock setups hiding from regular indicatorsK.I.R.A. is a new trading engine built to flag market setups before they show up on standard charts. Former...The TradingPub | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredLast note from me on thisJoel Peterson's free workshop breaks down a three step, three color system that works across stocks, ETFs, gol...The Cycle Code | SponsoredThe Claude AI company doubled in value... you missed itIn May, Anthropic raised money at a $965 billion valuation. Now, ahead of its IPO, investors are reportedly di...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
